{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:07:25Z","timestamp":1768442845315,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.prostaglandins.2015.07.002","type":"journal-article","created":{"date-parts":[[2015,7,19]],"date-time":"2015-07-19T14:06:43Z","timestamp":1437314803000},"page":"53-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"PA","title":["Aggravating effect of atorvastatin on indomethacin-induced gastric injury: Focus on PGE2, TNF-\u03b1, neutrophils and iNOS"],"prefix":"10.1016","volume":"121","author":[{"given":"F. Ilkay","family":"Alp Yildirim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zge","family":"Uyanik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hande","family":"\u00d6zyo\u011furt\u00e7u","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayd\u0131n","family":"G\u00fcrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u0131nar","family":"Atukeren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koray","family":"G\u00fcm\u00fc\u015fta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f6nmez","family":"Uyde\u015f-Do\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.prostaglandins.2015.07.002_bib0005","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ahj.2005.04.003","article-title":"Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention","volume":"151","author":"Zhou","year":"2006","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.prostaglandins.2015.07.002_bib0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2710.2009.01085.x","article-title":"A systematic review and meta-analysis on the therapeutic equivalence of statins","volume":"35","author":"Weng","year":"2010","journal-title":"J. Clin. Pharm. Ther."},{"issue":"5A","key":"10.1016\/j.prostaglandins.2015.07.002_bib0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.amjcard.2005.06.009","article-title":"Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol","volume":"96","author":"Liao","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2015.07.002_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/1153644-S0-000000000-00000","article-title":"Pleiotropic effects of statins evidence for benefits beyond LDL-cholesterol lowering","volume":"10","author":"Marzilli","year":"2010","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"7","key":"10.1016\/j.prostaglandins.2015.07.002_bib0025","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3748\/wjg.v11.i7.1040","article-title":"Inhibitory effect of fluvastatin on ileal ulcer formation in rats induced by nonsteroidal antiinflammatory drug","volume":"11","author":"Hagiwara","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.prostaglandins.2015.07.002_bib0030","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1080\/00365520600554444","article-title":"Effects of statins on experimental colitis in normocholesterolemic rats","volume":"41","author":"Jahovic","year":"2006","journal-title":"Scand. J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.prostaglandins.2015.07.002_bib0035","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1111\/j.1440-1746.2007.05021.x","article-title":"Gastric antisecretory and antiulcer effects of simvastatin in rats","volume":"22","author":"Tariq","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1\u20133","key":"10.1016\/j.prostaglandins.2015.07.002_bib0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejphar.2009.02.008","article-title":"Gastroprotective effect of simvastatin against indomethacin-induced gastric ulcer in rats: role of nitric oxide and prostaglandins","volume":"607","author":"Heeba","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.prostaglandins.2015.07.002_bib0045","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.bcp.2010.02.001","article-title":"Role of modulation of vascular endothelial growth factor and tumor necrosis factor-alpha in gastric ulcer healing in diabetic rats","volume":"79","author":"Baraka","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2015.07.002_bib0050","first-page":"199","article-title":"The pleiotropic effects and therapeutic potential of the hydroxy- methyl-glutaryl-CoA reductase inhibitors in gastrointestinal tract disorders: a comprehensive review","volume":"22","author":"Cortes-Bergoderi","year":"2013","journal-title":"J. Gastrointestin. Liver Dis."},{"issue":"20","key":"10.1016\/j.prostaglandins.2015.07.002_bib0055","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.3748\/wjg.v11.i20.3159","article-title":"Atorvastatin-induced severe gastric ulceration: a case report","volume":"11","author":"El-Hajj","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2015.07.002_bib0060","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4318\/tjg.2012.0393","article-title":"Effects of statins in an indomethacin-induced gastric injury model in rats","volume":"23","author":"\u00d6zbak\u0131\u015f-Dengiz","year":"2012","journal-title":"Turk. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2015.07.002_bib0065","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/gast.2000.16510","article-title":"NSAID-induced gastric damage in rats: requirement of inhibition of both cyclooxygenase 1 and 2","volume":"119","author":"Wallace","year":"2000","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.prostaglandins.2015.07.002_bib0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.bjp.0706201","article-title":"Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense","volume":"145","author":"Wallace","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2015.07.002_bib0075","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1152\/physrev.00004.2008","article-title":"NSAIDs, and gastric mucosal protection: why doesn\u2019t the stomach digest itself ?","volume":"88","author":"Wallace Prostaglandins","year":"2008","journal-title":"Physiol. Rev."},{"issue":"9699","key":"10.1016\/j.prostaglandins.2015.07.002_bib0080","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(09)60938-7","article-title":"Peptic ulcer disease","volume":"374","author":"Malfertheiner","year":"2009","journal-title":"Lancet"},{"issue":"2\u20133","key":"10.1016\/j.prostaglandins.2015.07.002_bib0085","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0014-2999(98)00162-9","article-title":"Prostaglandin, tumor necrosis factor alpha and neutrophils: causative relationship in indomethacin-induced stomach injuries","volume":"348","author":"Ding","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.prostaglandins.2015.07.002_bib0090","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3748\/wjg.v18.i18.2147","article-title":"Pathogenesis of NSAID-induced gastric damage: Importance of cyclooxygenase inhibition and gastric hypermotility","volume":"18","author":"Takeuchi","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2015.07.002_bib0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00296-011-2008-6","article-title":"The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in rheumatologic disorders: a comprehensive review","volume":"32","author":"Mihos","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.prostaglandins.2015.07.002_bib0100","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/ijc.23718","article-title":"Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention","volume":"123","author":"Xiao","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prostaglandins.2015.07.002_bib0105","first-page":"882","article-title":"Improvement method for the determination of blood glutathione","volume":"61","author":"Beutlar","year":"1963","journal-title":"J. Lab. Clin. Med."},{"issue":"3","key":"10.1016\/j.prostaglandins.2015.07.002_bib0110","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1742-481X.2011.00888.x","article-title":"Potential role of statins on wound healing: review of the literature","volume":"9","author":"Farsaei","year":"2012","journal-title":"Int. Wound J."},{"issue":"1","key":"10.1016\/j.prostaglandins.2015.07.002_bib0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2006.10.001","article-title":"Statin-associated adverse effects beyond muscle and liver toxicity","volume":"195","author":"Kiortsis","year":"2007","journal-title":"Atherosclerosis"},{"issue":"91\u201392","key":"10.1016\/j.prostaglandins.2015.07.002_bib0120","first-page":"641","article-title":"Statin use and risk of gastroduodenal ulcer and reflux esophagitis","volume":"56","author":"Fujii","year":"2009","journal-title":"Hepatogastroenterology"},{"issue":"8","key":"10.1016\/j.prostaglandins.2015.07.002_bib0125","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0002-9149(03)00124-3","article-title":"Comparison of the frequency of adverse events in patients treated with atorvastatin or simvastatin","volume":"91","author":"Abourjaily","year":"2003","journal-title":"Am. J. Cardiol."},{"issue":"5A","key":"10.1016\/j.prostaglandins.2015.07.002_bib0130","doi-asserted-by":"crossref","first-page":"11F","DOI":"10.1016\/j.amjcard.2005.06.008","article-title":"Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions","volume":"96","author":"Mason","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2015.07.002_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2008.12.005","article-title":"High-dose lovastatin decreased basal prostacyclin production in cultured endothelial cells","volume":"89","author":"Zhou","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"1","key":"10.1016\/j.prostaglandins.2015.07.002_bib0140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0021-9150(01)00547-0","article-title":"Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells","volume":"160","author":"Hern\u00e1ndez-Presa","year":"2002","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.prostaglandins.2015.07.002_bib0145","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/01.STR.0000174289.34110.b0","article-title":"Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month","volume":"36","author":"Mart\u00edn-Ventura","year":"2005","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.prostaglandins.2015.07.002_bib0150","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/01.fjc.0000194252.38683.68","article-title":"Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells","volume":"47","author":"G\u00f3mez-Hern\u00e1ndez","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2015.07.002_bib0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amjcard.2008.02.090","article-title":"Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metallo-proteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome","volume":"102","author":"G\u00f3mez-Hern\u00e1ndez","year":"2008","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2015.07.002_bib0160","first-page":"908","article-title":"Permissive role of neutrophils in pathogenesis of indomethacin-induced gastric lesions in rats","volume":"6","author":"Suzuki","year":"2000","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.prostaglandins.2015.07.002_bib0165","doi-asserted-by":"crossref","first-page":"D37","DOI":"10.1046\/j.1440-1746.2000.02143.x","article-title":"Regulatory mechanism of acid secretion in the damaged stomach: role of endogenous nitric oxide","volume":"15","author":"Takeuchi","year":"2000","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2015.07.002_bib0170","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1006\/phrs.2001.0801","article-title":"Protective role of nitric oxide in indomethacin-induced gastric ulceration by a mechanism independent of gastric acid secretion","volume":"43","author":"Khattab","year":"2001","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.prostaglandins.2015.07.002_bib0175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-2999(01)01119-0","article-title":"The role of nitric oxide in the gastric acid secretion induced by ischemia-reperfusion in the pylorus-ligated rat","volume":"13; 424","author":"Tanaka","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20136","key":"10.1016\/j.prostaglandins.2015.07.002_bib0180","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0928-4257(01)00034-1","article-title":"Current roles of nitric oxide in gastrointestinal disorders","volume":"95","author":"Cho","year":"2001","journal-title":"J. Physiol. Paris"},{"issue":"1","key":"10.1016\/j.prostaglandins.2015.07.002_bib0185","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-4804(03)00309-3","article-title":"Overexpression of inducible nitric oxide synthase in gastric mucosa of rats with portal hypertension: correlation with gastric mucosal damage","volume":"115","author":"Hsieh","year":"2003","journal-title":"J. Surg. Res."},{"issue":"5","key":"10.1016\/j.prostaglandins.2015.07.002_bib0190","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/hy1101.093103","article-title":"3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells","volume":"38","author":"Kolyada","year":"2001","journal-title":"Hypertension"},{"issue":"2\u20133","key":"10.1016\/j.prostaglandins.2015.07.002_bib0195","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0014-2999(96)00865-5","article-title":"Role of glutathione in nitric oxide-mediated injury to rat gastric mucosal cells","volume":"319","author":"Wakulich","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.prostaglandins.2015.07.002_bib0200","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.prostaglandins.2015.07.002_bib0205","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0009-9236(96)90218-0","article-title":"Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects","volume":"60","author":"Cilla","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.prostaglandins.2015.07.002_bib0210","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/faat.1996.0132","article-title":"Fertility and general reproduction studies in rats with the HMG-CoA reductase inhibitor, atorvastatin","volume":"32","author":"Dostal","year":"1996","journal-title":"Fundam. Appl. Toxicol."},{"issue":"6","key":"10.1016\/j.prostaglandins.2015.07.002_bib0215","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.HYP.37.6.1450","article-title":"HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species","volume":"37","author":"Wassmann","year":"2001","journal-title":"Hypertension"},{"issue":"9601","key":"10.1016\/j.prostaglandins.2015.07.002_bib0220","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","article-title":"The safety of statins in clinical practice","volume":"370","author":"Armitage","year":"2007","journal-title":"Lancet"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882315300034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882315300034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T20:28:48Z","timestamp":1537475328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882315300034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":44,"alternative-id":["S1098882315300034"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.07.002","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aggravating effect of atorvastatin on indomethacin-induced gastric injury: Focus on PGE2, TNF-\u03b1, neutrophils and iNOS","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}